Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
359 Results Found
Fact Sheet: AHA Priorities for Budget Reconciliation Package to Support America’s Hospitals and Health Systems
It is imperative that Congress invest in America’s hospitals and health systems to ensure
that the nation’s health care needs can be met today and into the future. The AHA supports
investments in infrastructure, such as the health care workforce, behavioral health, the
accessibility and affordability of health care coverage, emergency preparedness and the health
care supply chain, telehealth and cybersecurity, among other areas.
HHS outlines plan to lower the nation’s prescription drug costs
A new report released today by the Department of Health and Human Services outlines the Biden Administration’s plans to address high drug prices. The report recommends the pursuit of legislation that would enable price negotiation in Medicare Parts B and D, with those negotiated prices also available to the federal marketplace, commercial plans and employers who want to participate; Medicare Part D reform, including a cap on beneficiary out-of-pocket spending; and legislation that would slow price increases over time on existing drugs and speed entry of biosimilars and generics to the marketplace while increasing their prescribing by clinicians.
AHA Letter to House and Senate Sharing Priorities in Upcoming Budget Reconciliation Legislation
The American Hospital Association (AHA) would like to share hospital and health system priorities that would benefit patients and communities around the country that we would like to see included in the upcoming budget reconciliation legislation.
Senate holds hearing on anticompetitive drugmaker conduct
The Senate Judiciary Committee Subcommittee on Competition Policy, Antitrust, and Consumer Rights held a hearing on surging drug prices and anticompetitive conduct in the pharmaceutical industry.
House committee report shines light on pharma’s pricing, business practices
Fourteen leading U.S. drug companies from 2016 to 2020 spent $577 billion on stock buybacks and dividends, $56 billion more than they spent on research and development over the same period, according to a report released by the House Committee on Oversight and Reform.
HHS withdraws request for drug importation proposals
The Department of Health and Human Services withdrew requests for proposals on ways individuals could import prescription drugs from other countries where they are typically cheaper and companies could “reimport” insulin to sell at a lower price.
AHA expresses support for Drug-Price Transparency for Consumers Act
The AHA July 2 expressed support for the Drug-Price Transparency for Consumers Act of 2021 (S.2304).
Walmart Is Rolling Back Prices . . . This Time on Insulin
As patients and politicians continue searching for remedies to soaring insulin prices for diabetes patients, Walmart recently launched the first private-label version of the drug at less than half the price of brand-name versions.
AHA Voices Concern with Express Scripts’ New 340B Claims Reporting Policy
Amy Bricker
President
Express Scripts PBM
1 Express Way
Saint Louis, MO 63121
Dear Ms. Bricker: